Search results
Results will auto-populate based on filter selection.
611
Found 611 result(s)
Each year, we are required under the Workplace Safety and Insurance Act to conduct a value-for-money audit. The latest audit focused on the dispute resolution, appeals and…
Most Ontario businesses that have employees (including family members and sub-contractors) must register with us. We provide workplace insurance to 16 diverse industries and…
On this page: 1. Introduction 1.1. Background 2. Occupational disease legislative and policy scheme…
The Drug Advisory Committee was established in 2007 to guide WSIB on which drugs to include in our drug benefit plan as well as the medical conditions and criteria needed for…
Each year, we are required under the Workplace Safety and Insurance Act (WSIA) to have an external firm review the cost, efficiency, and effectiveness of one of our programs…
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A Indication(s) OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…